Filing Details

Accession Number:
0001225208-12-010879
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-05-02 16:02:16
Reporting Period:
2012-05-01
Filing Date:
2012-05-02
Accepted Time:
2012-05-02 16:02:16
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1385187 Covidien Plc COV Surgical & Medical Instruments & Apparatus (3841) 980624794
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1524349 C Bryan Hanson C/O Covidien
15 Hampshire Street
Mansfield MA 02048
Senior Vice President No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares Acquisiton 2012-05-01 9,702 $42.94 36,244 No 4 M Direct
Ordinary Shares Acquisiton 2012-05-01 8,835 $34.15 45,079 No 4 M Direct
Ordinary Shares Acquisiton 2012-05-01 8,000 $43.09 53,079 No 4 M Direct
Ordinary Shares Acquisiton 2012-05-01 7,473 $47.60 60,552 No 4 M Direct
Ordinary Shares Disposition 2012-05-01 34,010 $55.82 26,542 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Ordinary Shares Stock Option (Right to Buy) Disposition 2012-05-01 8,000 $0.00 8,000 $43.09
Ordinary Shares Stock Option (Right to Buy) Disposition 2012-05-01 8,835 $0.00 8,835 $34.15
Ordinary Shares Stock Option (Right to Buy) Disposition 2012-05-01 7,473 $0.00 7,473 $47.60
Ordinary Shares Stock Option (Right to Buy) Disposition 2012-05-01 9,702 $0.00 9,702 $42.94
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2017-07-01 No 4 M Direct
8,835 2018-11-30 No 4 M Direct
14,945 2019-11-30 No 4 M Direct
29,108 2020-11-30 No 4 M Direct
Footnotes
  1. The price reported is the weighted average price. Shares were sold in multiple transactions at prices ranging from $55.77 to $55.87. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a securityholder of the Issuer, full information regarding the number of shares sold at each price.
  2. Fully exercisable.